On July 21, 2026, Dallah Healthcare Company announced the completion of its sale of approximately 31.21% shareholding in Dr. Mohammed Bin Rashed Al Fagih & Partners Company to Dr. Soliman Abdel Kader Fakeeh Hospital Co., with the transaction closing on July 20, 2026 following fulfillment of all conditions. The total consideration for the transaction amounted to SAR 497,983,407, of which SAR 466,774,106.13 was paid directly to Dallah Healthcare upon completion. A portion of the total cash consideration amounting to SAR 100 million (of which Dallah Healthcare is entitled to 31.21%) has been placed in an escrow account for six months to cover any potential breaches or issues discovered in the target company post-completion.

Original announcement:

Important Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.